Yolk sac tumor in aberrant localization.
Suc
E
E
Service de Pédiatrie, Institut Gustave Roussy, Villejuif, France.
Flamant
F
F
Lacombe
M J
MJ
Valteau
D
D
Lemerle
J
J
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis; D001761:Bleomycin / Q000008:administration & dosage; D002277:Carcinoma / Q000175:diagnosis; D002610:Cheek; D002675:Child, Preschool; D002945:Cisplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D003609:Dactinomycin / Q000008:administration & dosage; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008649:Mesonephroma / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D009062:Mouth Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D012074:Remission Induction; D014747:Vinblastine / Q000008:administration & dosage; D000509:alpha-Fetoproteins / Q000032:analysis
D014408:Biomarkers, Tumor; D000509:alpha-Fetoproteins; D001761:Bleomycin; D003609:Dactinomycin; D014747:Vinblastine; D003520:Cyclophosphamide; D002945:Cisplatin